Alkaloid AD Logo

Alkaloid AD

Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.

ALK | MSE

Overview

Corporate Details

ISIN(s):
MKALKA101011
LEI:
Country:
North Macedonia
Address:
Blvd. Aleksandar Makedonski 12, 1000 Skopje
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alkaloid AD is a pharmaceutical company with over eight decades of experience in the manufacturing of drugs, cosmetics, and chemical products, as well as the processing of botanical raw materials. The company's operations are structured into two primary profit centers: Pharmacy, and Chemistry, Cosmetics, and Herbal Medicine. Its product portfolio encompasses a wide range of generic drugs, with a focus on oral solid dosage forms, alongside various cosmetic and herbal products. The company also engages in pharmaceutical innovation, holding an international patent for a value-added medicine, liquid Omeprazole. Alkaloid AD serves both healthcare professionals and the general consumer market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Alkaloid AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alkaloid AD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alkaloid AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ensysce Biosciences, Inc. Logo
Developing safer opioids with abuse-deterrent and overdose protection technology for severe pain.
United States of America
ENSC
Entera Bio Ltd. Logo
Developing oral versions of injectable drugs for osteoporosis, hypoparathyroidism, and obesity.
United States of America
ENTX
Entero Therapeutics, Inc. Logo
Develops targeted oral therapies for a range of gastrointestinal (GI) diseases.
United States of America
ENTO
Entrada Therapeutics, Inc. Logo
Developing intracellular therapeutics for rare neuromuscular diseases via its EEV™ platform.
United States of America
TRDA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea
183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden
ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea
446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden
EQL
Equillium, Inc. Logo
Clinical-stage biotech creating therapies for severe autoimmune and inflammatory disorders.
United States of America
EQ
Erasca, Inc. Logo
Clinical-stage oncology company developing therapies targeting the RAS/MAPK pathway in cancer.
United States of America
ERAS

Talk to a Data Expert

Have a question? We'll get back to you promptly.